Mark John Gilbert insider trades
Open-market stock purchases and sales by Mark John Gilbert, Director at Indaptus Therapeutics, Inc, from SEC Form 4 filings since Dec 1, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- INDP Indaptus Therapeutics, Inc: other filings, last Jun 10, 2025